Compare Flagstar Bank NA (FLG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flagstar Bank NA vs Repligen Corporation Common Stock — how do they compare? Flagstar Bank NA trades at $11.07 (market cap $4.61B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 2.5× Flagstar Bank NA's market cap, and Flagstar Bank NA pays a 0.36% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flagstar Bank NA for 23 Days and Repligen Corporation Common Stock for 0 Days on average.
| FLG | RGEN | |
|---|---|---|
Market Cap | $4.61B | $11.31B |
Volume | 4,112,400 | 1,216,919 |
Sector | Financials | Health |
52-Week High | $15.36 | $194.57 |
52-Week Low | $10.72 | $102.87 |
Typical Hold Time | 23 Days | 0 Days |
Enterprise Value | $15.13B | $11.20B |
Dividend Yield | 0.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Flagstar Bank (FLG) trades at $11.21, down 0.88% today, with a bearish technical outlook despite positive analyst sentiment. The stock shows mixed fundamentals with a low P/B ratio of 0.6x but elevated P/E of 370x due to recent profitability challenges. Recent Q2 2026 earnings missed expectations, though the company announced a $250 million share repurchase program and maintains a dividend. Cash flow trends improved in 2026 with positive operating cash flow of $162 million versus negative $181 million in 2025.
The investment case balances analyst optimism (60% buy ratings, $16.81 consensus target) against weak technicals and earnings volatility. Key opportunities include the discounted valuation relative to book value and strategic initiatives like the Fiserv partnership. Risks include inconsistent earnings performance, high interest expense ($2.75B in 2025), and bearish momentum indicators. The stock presents a value opportunity if operational improvements continue.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
